Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | ACHE | P22303 | 1/20 | 0.63 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.58 |
| ▸ | JUN | P05412 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | TNFSF11 | O14788 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | VCP | P55072 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8350024 | 0.90 | TSHR (0.60) | TSHRACHENR3C1JUNNFKB1 | |
| SCHEMBL28879153 | 0.86 | ACHE (0.65) | TSHRACHEALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL28879154 | 0.85 | ACHE (0.63) | TSHRACHEALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL30468737 | 0.84 | ACHE (0.57) | TSHRACHENR3C1JUNNFKB1 | |
| SCHEMBL30474574 | 0.83 | ACHE (0.61) | TSHRACHEALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL2565359 | 0.83 | ACHE (0.61) | TSHRACHEALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL10960395 | 0.83 | ACHE (0.61) | TSHRACHEALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL10425842 | 0.82 | TSHR (0.66) | TSHRNR3C1JUNNFKB1TNFSF11 | |
| SCHEMBL17703857 | 0.81 | MAPT (0.65) | TSHRACHEALDH1A1KDM4EMAPT | |
| SCHEMBL2729632 | 0.81 | TSHR (0.64) | TSHRNR3C1JUNNFKB1TNFSF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119490612-A | Solid catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119490410-A | Ether ester compound, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | claimed |
| EP-1058919-A1 | IDENTIFIABLE MARKING COMPOSITIONS AND METHODS | Tracking Technologies, Inc. (US) | 2000-12-13 | — | — | EP | claimed |
| WO-1999045514-A1 | IDENTIFIABLE MARKING COMPOSITIONS AND METHODS | TRACKING TECHNOLOGIES, INC. (US) | 1999-09-10 | — | — | WO | claimed |
| CN-119490612-A | Solid catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-119490410-A | Ether ester compound, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | disclosed |
| US-20230322647-A1 | PCNHCP METAL COMPLEXES AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2023-10-12 | — | — | US | disclosed |
| US-20230244143-A9 | RADIATION-SENSITIVE RESIN COMPOSITION, METHOD OF FORMING RESIST PATTERN, AND COMPOUND | JSR CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| CN-110891615-B | System and method for selecting and releasing fragrance | 阿甘香气及精细化学有限公司 | 2022-08-05 | — | — | CN | disclosed |
| EP-3527562-B1 | MICROTUBULE PROTEIN INHIBITOR | SHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD (CN) | 2022-04-06 | — | — | EP | disclosed |
| WO-2021094268-A1 | GINGEROL COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH SA (CH) | 2021-05-20 | — | — | WO | disclosed |
| US-10724072-B2 | Use of phospho-Akt as a biomarker of drug response | BASILEA PHARMACEUTICA AG (CH) | 2020-07-28 | — | — | US | disclosed |
| US-7310902-B2 | Personal safety device | WILLIAMS JANET ELIZABETH | 2007-12-25 | — | — | US | disclosed |
| WO-2007104783-A2 | 1,4 -DI SUBSTITUTED 3-CYANO-PYRIDONE DERIVATIVES AND THEIR USE AS POSITIVE MGLUR2-RECEPT0R MODULATORS | ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. (US) | 2007-09-20 | — | — | WO | disclosed |
| US-20070043061-A1 | Furazanobenzimidazoles | BASILEA PHARMACEUTICA AG | 2007-02-22 | — | — | US | disclosed |
| US-20070043061-A1 | Furazanobenzimidazoles | BASILEA PHARMACEUTICA AG | 2007-02-22 | — | — | US | disclosed |
| US-20060117981-A1 | Personal safety device | WILLIAMS JANET E | 2006-06-08 | — | — | US | disclosed |
| CN-1771521-A | Personal safety device | WILLIAMS JANET E (GB) | 2006-05-10 | — | — | CN | disclosed |
| EP-1606779-A1 | PERSONAL SAFETY DEVICE | Williams, Janet Elisabeth (GB) | 2005-12-21 | — | — | EP | disclosed |
| WO-2004086323-A1 | PERSONAL SAFETY DEVICE | WILLIAMS JANET ELIZABETH (GB) | 2004-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10724072-B2 | Use of phospho-Akt as a biomarker of drug response | AKT3, AKT1S1, AKT2 | TSHR 818/4885ACHE 4815/4885NR3C1 181/4885 |
| US-20230322647-A1 | PCNHCP METAL COMPLEXES AND USES THEREOF | PIN4, HIRIP3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | TSHR 4417/4885ACHE 3352/4885NR3C1 585/4885 |
| US-20070043061-A1 | Furazanobenzimidazoles | FOXO1, CYP2F1, OXER1 | TSHR 1025/4885ACHE 2937/4885NR3C1 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.